Authors: Snijdewint, FGM von Mensdorff-Pouilly, S Karuntu-Wanamarta, AH Verstraeten, AA Livingston, PO Hilgers, J Kenemans, P

Citation: Fgm. Snijdewint et al., Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients, INT J CANC, 93(1), 2001, pp. 97-106

Authors: Ryuko, K Schol, DJ Snijdewint, FGM von Mensdorff-Pouilly, S Poort-Keesom, RJJ Karuntu-Wanamarta, YA Verstraeten, RA Miyazaki, K Kenemans, P Hilgers, J

Citation: K. Ryuko et al., Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1, TUMOR BIOL, 21(4), 2000, pp. 197-210

Authors: von Mensdorff-Pouilly, S Verstraeten, AA Kenemans, P Snijdewint, FGM Kok, A Van Kamp, GJ Paul, MA Van Diest, PJ Meijer, S Hilgers, J

Citation: S. Von Mensdorff-pouilly et al., Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin, J CL ONCOL, 18(3), 2000, pp. 574-583

Authors: von Mensdorff-Pouilly, S Snijdewint, FGM Verstraeten, AA Verheijen, RHM Kenemans, P

Citation: S. Von Mensdorff-pouilly et al., Human MUC1 mucin: a multifaceted glycoprotein, INT J B MAR, 15(4), 2000, pp. 343-356

Authors: von Mensdorff-Pouilly, S Petrakou, E Kenemans, P van Uffelen, K Verstraeten, AA Snijdewint, FGM van Kamp, GJ Schol, DJ Reis, CA Price, MR Livingston, PO Hilgers, J

Citation: S. Von Mensdorff-pouilly et al., Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1peptides and N-acetylgalactosamine (GalNAc) peptides, INT J CANC, 86(5), 2000, pp. 702-712

Authors: Snijdewint, FGM von Mensdorff-Pouilly, S Karuntu-Wanamarta, AH Verstraeten, AA van Zanten-Przybysz, I Hummel, P Nijman, HW Kenemans, P Hilgers, J

Citation: Fgm. Snijdewint et al., Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls, CANCER IMMU, 48(1), 1999, pp. 47-55